市場調查報告書
商品編碼
1597155
亞太地區非侵入性減脂市場預測至 2031 年 - 區域分析 - 按技術(冷凍溶脂、雷射溶脂、超音波等)和最終用戶(醫院、皮膚科和美容診所以及其他最終用戶)Asia Pacific Noninvasive Fat Reduction Market Forecast to 2031 - Regional Analysis - by Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others) and End User (Hospitals, Dermatology & Cosmetic Clinics, and Other End Users) |
2023年亞太地區非侵入性減脂市值為4.1508億美元,預計2031年將達到17.0985億美元;預計2023年至2031年複合年成長率為19.4%。
產品核准與創新推動亞太無創減脂市場
下表重點介紹了市場上營運的公司推出的以非侵入性減脂為中心的產品。
日期
公司名稱
產品名稱
產品描述
1 月 21 日
艾伯維公司
酷塑精英
CoolSculpting Elite 是一項經過臨床驗證的技術,可靶向、冷凍和消除經過處理的脂肪細胞。該產品已獲得 FDA 批准,可治療身體九個區域的可見脂肪隆起,包括大腿、腹部和側腹,以及胸罩脂肪、背部脂肪、臀部下方、上臂以及頦下和下頜下區域。
4 月 22 日
超大型油輪
VLCC Lipo-1060
VLCC Lipo-1060 治療採用最新的特定波長雷射裝置,可實現無痛的非侵入性塑身瘦身,並確保在保護皮膚的情況下僅消除脂肪細胞。治療中使用的技術已被臨床證明可以持續減少腹部和身體其他部位的脂肪輪廓,並且對所有皮膚類型都具有出色的安全性。
23年3月
truBody品牌
truBody 品牌是一款屢獲殊榮的療程組合,旨在提供客製化、方便、完整的減脂和肌肉塑形方法,療程僅需 15 分鐘。用於減脂的 truSculpt(以前稱為 truSculpt iD)是一種快速有效的組合方法,使醫生和患者能夠提供減脂和塑形肌肉的最佳效果。
此外,Medicis 的 Liposonix 是一種新的治療技術,使用高強度聚焦超音波設備來消除皮下脂肪。據報道,該公司獲得 FDA 批准用於非侵入性腰圍縮小。此類創新產品的批准和推出預計將在 2023 年至 2031 年期間促進非侵入性減脂市場的成長。
亞太地區無創減脂市場概況
亞太地區包括中國、日本、印度、澳洲、韓國等主要國家、亞太地區其他地區。亞太地區非手術減脂市場複合年成長率最高。在亞太地區,中國在非手術減脂市場上佔有主要佔有率。對美容手術的需求不斷成長是影響2023-2031年預測期內非手術減脂市場區域成長的關鍵因素之一。
亞太地區無創減脂市場收入及 2031 年預測(百萬美元)
亞太地區無創減脂市場區隔
亞太地區無創減脂市場按技術、最終用戶和國家分類。
根據技術,亞太無創減脂市場分為冷凍溶脂、雷射溶脂、超音波等。 2023 年,冷凍溶脂領域佔據最大的市場佔有率。
就最終用戶而言,亞太地區非侵入性減脂市場分為醫院、皮膚科診所和美容診所等。 2023 年,皮膚科診所和美容診所細分市場佔據最大的市場佔有率。
依國家/地區分類,亞太地區無創減脂市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年,中國在亞太無創減脂市場佔有率中佔據主導地位。
Cynosure LLC、Alma Lasers Ltd、Cutera Inc、Fotona、Sciton Inc、Lumenis、Venus Concept Inc 和 Candela Corporation 是亞太地區非侵入性減脂市場的一些領先公司。
The Asia Pacific noninvasive fat reduction market was valued at US$ 415.08 million in 2023 and is projected to reach US$ 1,709.85 million by 2031; it is estimated to register a CAGR of 19.4% from 2023 to 2031.
Product Approvals and Innovations Boost Asia Pacific Noninvasive Fat Reduction Market
The table below highlights the noninvasive fat reduction-centric products launched by companies operating in the market.
Date
Company Name
Product Name
Product Description
Jan-21
AbbVie, Inc.
CoolSculpting Elite
CoolSculpting Elite is a clinically proven technology to target, freeze, and eliminate treated fat cells. The product is FDA-cleared to treat visible fat bulges in nine areas of the body, including the thigh, abdomen, and flank, as well as bra fat, back fat, underneath the buttocks, upper arm, and the submental and submandibular areas.
Apr-22
VLCC
VLCC Lipo-1060
VLCC Lipo-1060 treatment uses the latest laser appliances of specific wavelengths that enable noninvasive body contouring and slimming without pain and ensure that only fat cells are eliminated with skin protection. The technology used in the treatment has been clinically proven to consistently reduce the fat contour in the abdomen and other areas of the body, with an excellent safety profile in all skin types.
Mar-23
truBody Brand
truBody Brand is an award-winning treatment pair intended for a customized, convenient, and complete approach to fat reduction and muscle toning with only a 15-minute treatment duration. The truSculpt (formerly truSculpt iD) for fat reduction is a fast and effective combination approach, allowing practitioners and patients to provide optimal results for reducing fat and toning muscle.
Additionally, Medicis's Liposonix is a new treatment technique that uses a high-intensity focused ultrasound device to eliminate fat beneath the skin. The company reportedly received FDA approval for noninvasive waist circumference reduction. Such innovative product approvals and launches are expected to enhance the market growth of noninvasive fat reduction during 2023 - 2031.
Asia Pacific Noninvasive Fat Reduction Market Overview
Asia Pacific region covers major countries such as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Asia Pacific region accounts highest CAGR for the non-surgical fat reduction market. In the Asia Pacific region, China holds major share for the non-surgical fat reduction market. Rising demand for aesthetic procedures is one of the key factors that influences regional growth of non-surgical fat reduction market for the forecast period 2023-2031.
Asia Pacific Noninvasive Fat Reduction Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Noninvasive Fat Reduction Market Segmentation
The Asia Pacific noninvasive fat reduction market is categorized into technology, end user, and country.
Based on technology, the Asia Pacific noninvasive fat reduction market is categorized into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held the largest market share in 2023.
In terms of end user, the Asia Pacific noninvasive fat reduction market is segmented into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held the largest market share in 2023.
By country, the Asia Pacific noninvasive fat reduction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific noninvasive fat reduction market share in 2023.
Cynosure LLC, Alma Lasers Ltd, Cutera Inc, Fotona, Sciton Inc, Lumenis, Venus Concept Inc, and Candela Corporation are some of the leading companies operating in the Asia Pacific noninvasive fat reduction market.